McMaster University

McMaster University

Ronald F. Carter

, PhD, DVM

Professor Emeritus (2014)
Pathology and Molecular Medicine

McMaster University
rcarter@mcmaster.ca

Ronald F. Carter

Faculty Biography

Education and Professional Standing

PhD, Veterinary Clinical Pathology, University of Guelph, 1988
DVM, Ontario Veterinary College, 1983
MSc, Faculty of Medicine, University of Toronto, 1980

Interests

Research and Clinical Focus

Dr. Carter is the Director of Laboratory Genetic Services for the Hamilton Regional Laboratory Medicine Program, which has a catchment of 2.3 million people in the central south region of Ontario. He is also Head of the laboratory cancer genetics service, which provides diagnostic cancer genetic testing (cytogenetic and molecular test services, including hereditary cancer syndromes). His research is primarily based upon collaborative studies involving clinical correlations of diagnostic or prognostic genetic markers.

Academic Interests

Dr. Carter’s major teaching activity is training post-doctoral fellows registered in our joint training program in laboratory diagnostic genetics (accredited by the Canadian College of Medical Geneticists). He is also involved in the Undergraduate Medical Program.


Team Members

Dr. Murray Potter, Dr. John Waye

Selected Publications

  • Hilmi O, Knight JA Glendon G, Yazici H, Carson N, Ainsworth PJ, Taylor SAM, Feilotter H, Carter RF, Boyd NF, Andrulis IL, for the Ontario Cancer Genetics Network (2003): Individual and Family Characteristics Associated with BRCA1 and BRCA2 Mutations in an Ontario Population-based Series from the Cooperative Family Registry for Breast Cancer Studies. J Med Genet, 2003 Aug;40(8):e91.
  • Nowaczyk MJ, Zeesman S, Kam A, Taylor SA, Carter RF, Whelan DT (2004): Boy with 47,XXY,del(15)(q11.2q13) karyotype and Prader-Willi syndrome: a new case and review of the literature. Am J Med Genet. 2004 Feb 15;125A(1):73-6.
  • Lavoie J, Carter R, Drouin R, Lebel M (2005) Increased frequency of multiradial chromosome structures in mouse embryonic fibroblasts lacking functional Werner syndrome protein and poly(ADP-ribose) polymerase-1. Cancer Genetic Cytogenet 156:134-143.
  • Sharpe N, Carter RF (2006):Genetic Testing:Care, Consent, and Liability.Wiley & Sons, Hoboken NJ, 550 pp.
  • Zubairi MS, Carter RF, Ronen, GM (2008): A male phenotype with Aicardi syndrome. J Child Neurol in press JCN-2008-03-0039.
  • Miller FA, Krueger P, Christensen R, Ahern C, Carter R, Kamel-Reid S (2009): Postal survey of physicians and laboratories: Practices and perceptions of molecular oncology testing. BMC Health Serv Res 30:131-46 (doi:10.1186/1472-6963-9-131).
  • Zanke B, Hawken S, Carter R, Chow D (2010): A genetic approach to stratification of risk for age-related macular degeneration. Can J Ophthalmol 45:22-7.
  • Bassett AS, Costain G, Fung WL, Russell KJ, Pierce L, Kapadia R, Carter RF, Chow EW, Forsythe PJ (2010):  Clinically detectable copy number variations in a Canadian catchment population of schizophrenia.  J Psychiatr Res 44:1005-9.
Valid XHTML 1.0 Transitional Level Double-A conformance, W3C WAI Web Content Accessibility Guidelines 2.0